A Clinical Trial to Investigate the Safety and Tolerability, Efficacy, Pharmacokinetics, Pharmacodynamics and Immunogenicity of 2 Dose Regimens of ARGX-117 in Adults With Multifocal Motor Neuropathy

Clinical trial NCT05225675 · COMPLETED

Trial details

NCT number: NCT05225675
Sponsor: argenx
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Multifocal Motor Neuropathy

Start date: 2022-03-31
Primary completion: 2024-06-04
Enrollment: 54

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.